Lawyer opposes Allergan’s bid for interlocutory appeal in FCA suit
18-01-2021
Fed Circuit remands Allergan inventorship dispute
11-11-2020
FTC demands AbbVie divests Crohn’s treatment in Allergan buyout
07-09-2020
rafapress / Shutterstock.com
A California judge has allowed a patent attorney to proceed with his claims against Allergan which allege the pharmaceutical company fraudulently obtained patents to monopolise pricing.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Allergan, False Claims Act, Zachary Silbersher, patents, Namenda XR, Namzaric, fraud, monopoly
